Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes

scientific article published on January 2007

Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1022027447
P356DOI10.1291/HYPRES.30.23
P698PubMed publication ID17460368
P5875ResearchGate publication ID6369579

P2093author name stringKazuomi Kario
Satoshi Hoshide
Kazuyuki Shimada
Toshio Fukuda
Joji Ishikawa
Kazuo Eguchi
Hidenori Tomizawa
Toshio Numao
P433issue1
P921main subjectmetforminQ19484
insulin resistanceQ1053470
P304page(s)23-30
P577publication date2007-01-01
P1433published inHypertension ResearchQ15762136
P1476titleComparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes
P478volume30

Reverse relations

cites work (P2860)
Q37453128Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study
Q47095883Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats
Q46030901Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes.
Q51382232Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
Q36068914New targets to treat obesity and the metabolic syndrome
Q43260422Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention
Q27024799PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
Q46880186Platelet activation in subjects with impaired glucose tolerance
Q82475366Relationship between Two AMI Risk Factors: Low Serum Lipoprotein Lipase Mass and Hypoadiponectinemia
Q24235718Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Q24240522Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Q24244739Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Q38974109The effect of pioglitazone on aldosterone and cortisol production in HAC15 human adrenocortical carcinoma cells
Q37241742The effect of thiazolidinediones on BMD and osteoporosis
Q24642274Treating prediabetes with metformin: systematic review and meta-analysis

Search more.